Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

Kazumoto Murata(National Center for Global Health and Medicine), T. Jake Liang(National Institutes of Health), Martin Lechmann(Roche (Switzerland)), Ming Qiao(Xinjiang Medical University), Toshiaki Gunji(NTT Medical Center), Harvey J. Alter(National Institutes of Health Clinical Center)
Proceedings of the National Academy of Sciences
May 14, 2003
Cited by 170


Related Papers